Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Immunocore Holdings PLC Sponsored ADR (IMCR) reported revenue of $103.69 million, up 29.2% over the same period last year. EPS came in at$ 0, compared to $0.17 in the year-ago quarter.The reported revenue represents a surprise of +3.8% over the Zacks Consensus Estimate of$ 99.9 million. With the consensus EPS estimate being -$0.30, the EPS surprise was +100%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...